Pharmaceutical Policy and Practice Research Centre

Research output

Research output per year 2016 2020 2021 2022 2023 2024

• 211 Article
• 132 Letter
• 82 Review article
• 25 Comment/debate
• 86 More
  • 24 Chapter
  • 20 Entry for encyclopedia/dictionary
  • 17 Meeting Abstract
  • 11 Editorial
  • 6 Book
  • 2 Commissioned report
  • 2 Other report
  • 2 Foreword/postscript
  • 1 Other chapter contribution
  • 1 Literature review

Research output per year

Research output per year

Search results

• 2020

  Exploration of a New Source of Sustainable Nanomaterial from the Koh-e-Suleiman Mountain Range of Pakistan for Industrial Applications

  Nirwan, J., Farhaj, S., Chaudhary, M. M., Khizer, Z., Hasan, S. S., Angelis-Dimakis, A., Gill, A., Rasheed, H., Abbas, N., Arshad, M. S., Hussain, T., Shahzad, Y., Yousaf, A., Chohan, T. A., Hussain, T., Merchant, H., Akram, M. R., Khan, T. M., Ashraf, M., Conway, B., & 1 othersGhori, M. U., 17 Jan 2020, In: Scientific Reports. 10, 1, 14 p., 577.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Nanostructured materials 100%
  • nanomaterial 91%
  • mountain range 86%
  • Montmorillonite 77%
  • Industrial applications 73%
  5 Citations (Scopus)

• Factors associated with inappropriate dispensing of antibiotics among non-pharmacist pharmacy workers

  Asghar, S., Atif, M., Mushtaq, I., Malik, I., Hayat, K. & Babar, Z. U. D., 1 Jun 2020, In: Research in Social and Administrative Pharmacy. 16, 6, p. 805-811 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Pharmacy 100%
  • Occupational Groups 71%
  • Antimicrobial Agent 69%
  • Anti-Bacterial Agents 65%
  • Pakistan 37%
  31 Citations (Scopus)

• Global antibiotics use and resistance

  Aldeyab, M., López-Lozano, J. M. & Gould, I. M., 16 Jun 2020, Global Pharmaceutical Policy. Babar, Z-U-D. (ed.). Palgrave Macmillan, p. 331-344 14 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

  • Microbial Drug Resistance 100%
  • Anti-Bacterial Agents 65%
  • Public Health 17%
  • Bacteria 16%
  • driver 16%
  29 Citations (Scopus)

• Global Pharmaceutical Policy

  Babar, Z. (ed.), 16 Jun 2020, 1st ed. Springer Singapore. 365 p.

  Research output: Book/Report › Book › peer-review

  • Drug and Narcotic Control 100%
  • pharmaceutical 80%
  • medicine 62%
  • Pharmacy Research 49%
  • Kyrgyzstan 49%
  2 Citations (Scopus)

• Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis

  Nirwan, J., Hasan, S. S., Babar, Z-U-D., Conway, B. & Ghori, M. U., 2 Apr 2020, In: Scientific Reports. 10, 1, 14 p., 5814.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Esophageal Diseases 100%
  • Gastroesophageal Reflux 79%
  • Meta-Analysis 57%
  • Systematic Reviews 57%
  • United Nations 21%
  169 Citations (Scopus)

• Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis

  Kow, C. S. & Hasan, S. S., 1 Oct 2020, In: Infection. 48, 5, p. 805-806 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  12 Citations (Scopus)

• Grounded Theory in Pharmacy Practice Research

  Haloub, R. & Babar, Z., 22 Apr 2020, Pharmacy Practice Research Methods. Babar, Z-U-D. (ed.). 2nd ed. Springer Singapore, p. 155-170 16 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

  • Pharmacy practices 100%
  • grounded theory 67%
  • symbolic interactionism 31%
  • methodology 12%
  • literature 10%
  2 Citations (Scopus)

• Herbal medicines: a cross-sectional study to evaluate the prevalence and predictors of use among Jordanian adults

  El-Dahiyat, F., Rashrash, M., Abuhamdah, S., Abu Farha, R. & Babar, Z-U-D., 21 Jan 2020, In: Journal of Pharmaceutical Policy and Practice. 13, 1, 9 p., 2.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hypertensive 100%
  • Herbal Medicine 80%
  • cross-sectional study 72%
  • medicine 52%
  • Cross-Sectional Studies 47%
  50 Citations (Scopus)

• Impact of a global leader on pharmaceutical practice and policy around the world

  Alves da Costa, F., Henman, M., Hughes, C., Leufkens, H., Babar, Z-U-D., McElnay, J. & Schulz, M., 21 Aug 2020, In: Journal of Pharmaceutical Policy and Practice. 13, 5 p., 51.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Drug and Narcotic Control 100%
  • Psychological Practice 89%
  • pharmaceutical 80%
  • Pharmaceutical 63%
  • Pharmacy practices 58%

• Impact of National Drug Pricing Policy 2018 on access to medicines in Lahore division, Pakistan: a pre-post survey study using WHO/HAI methodology

  Saeed, A., Saeed, H., Saleem, Z., Yang, C., Jiang, M., Zhao, M., Ji, W., Aziz, M. M., Khan, F. U., Gillani, A. H., Atif, N., Fang, Y. & Babar, Z-U-D., 8 Oct 2020, In: BMJ Open. 10, 10, 9 p., e034720.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Pakistan 100%
  • Global Health 86%
  • Costs and Cost Analysis 55%
  • Pharmaceutical Preparations 36%
  • Public Sector 27%
  11 Citations (Scopus)

• Integrating pharmaceutical systems strengthening in the current global health scenario: three ‘uncomfortable truths’

  Hafner, T., Banda, M., Kohler, J., Babar, Z-U-D., Lumpkin, M., Adeyeye, M. C., Nfor, E., Aboagye-Nyame, F. & Guzman, J., 25 Jun 2020, In: Journal of Pharmaceutical Policy and Practice. 13, 1, 4 p., 38.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Global Health 100%
  • pharmaceutical 94%
  • Pharmaceutical 74%
  • scenario 74%
  • Organizational Efficiency 53%
  5 Citations (Scopus)

• Interventions to improve spontaneous adverse drug reaction reporting by healthcare professionals and patients: systematic review and meta-analysis

  Paudyal, V., Al-hamid, A., Bowen, M., Hadi, M. A., Hasan, S. S., Jalal, Z. & Stewart, D., 1 Sep 2020, In: Expert Opinion on Drug Safety. 19, 9, p. 1173-1191 19 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  File

  • Drug-Related Side Effects and Adverse Reactions 100%
  • Meta-Analysis 80%
  • Systematic Reviews 79%
  • Delivery of Health Care 65%
  • Expert Testimony 56%
  26 Citations (Scopus)

• Is it worth the wait? Should Chloroquine or Hydroxychloroquine be allowed for immediate use in CoViD-19?

  Hasan, S. S., Kow, C. S. & Merchant, H., 31 Mar 2020, In: British Journal of Pharmacy. 5, 1, 5 p., 745.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Hydroxychloroquine 100%
  • Coronavirus 93%
  • Chloroquine 84%
  • Pneumonia 17%
  • Pandemics 11%

• Mechanical and release behaviour of theophylline from matrix tablets containing psyllium powder in combination with grewia polysaccharides

  Nep, E. I., Kaur, N., Shaboun, S., Adebisi, A. O., Smith, A. M., Conway, B. R. & Asare-Addo, K., 1 Apr 2020, In: Colloids and Surfaces B: Biointerfaces. 188, 7 p., 110809.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Grewia 100%
  • Psyllium 81%
  • Polysaccharides 75%
  • polysaccharides 69%
  • tablets 68%
  4 Citations (Scopus)

• Medicines Access, Use and Pharmaceutical Health System Issues: Reflections, Thoughts and Points to Consider

  Babar, Z. & Scahill, S. L., 16 Jun 2020, Global Pharmaceutical Policy. Babar, Z-U-D. (ed.). 1st ed. Springer Singapore, p. 345-365 21 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

  • Thinking 100%
  • pharmaceutical 94%
  • Drug and Narcotic Control 78%
  • medicine 73%
  • Health 49%
  2 Citations (Scopus)

• Medicines Safety in the Globalized Context

  Hussain, R., Azmi Hassali, M. & Babar, Z-U-D., 16 Jun 2020, Global Pharmaceutical Policy. Babar, Z-U-D. (ed.). 1st ed. Springer Singapore, p. 1-28 28 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

  • Pharmacovigilance 100%
  • medicine 55%
  • Safety 44%
  • Pharmacoepidemiology 30%
  • Pakistan 24%
  8 Citations (Scopus)

• Meta-analysis of Effect of Statins in Patients with COVID-19

  Kow, C. S. & Hasan, S. S., 1 Nov 2020, In: American Journal of Cardiology. 134, p. 153-155 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

  • Coronavirus 100%
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors 77%
  • Meta-Analysis 59%
  • Drug Repositioning 36%
  • Pandemics 28%
  125 Citations (Scopus)

• Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis

  Hasan, S. S., Kow, C. S., Hadi, M. A., Zaidi, S. T. R. & Merchant, H. A., 1 Dec 2020, In: American Journal of Cardiovascular Drugs. 20, 6, p. 571-590 20 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Coronavirus 100%
  • Renin-Angiotensin System 82%
  • Meta-Analysis 59%
  • Systematic Reviews 58%
  • Angiotensin Receptor Antagonists 49%
  34 Citations (Scopus)

• Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis

  Hasan, S. S., Capstick, T., Ahmed, R., Kow, C. S., Mazhar, F., Merchant, H. A. & Zaidi, S. T. R., 1 Nov 2020, In: Expert Review of Respiratory Medicine. 14, 11, p. 1149-1163 15 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Coronavirus 100%
  • Adult Respiratory Distress Syndrome 87%
  • mortality 66%
  • Adrenal Cortex Hormones 64%
  • Meta-Analysis 59%
  186 Citations (Scopus)

• MUCO-DIS: a New AFM-Based Nanoscale Dissolution Technique

  Ghori, M. U., Nirwan, J., Asim, T., Chahid, Y., Farhaj, S., Khizer, Z., Timmins, P. & Conway, B., 1 Jul 2020, In: AAPS PharmSciTech. 21, 5, 11 p., 142.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Drug Liberation 100%
  • Dissolution 75%
  • Polymers 60%
  • Pectins 47%
  • Large Intestine 40%
  4 Citations (Scopus)

• Needs assessment and impact of COVID-19 on pharmacy professionals in 31 commonwealth countries

  Ashiru-Oredope, D., Chan, A. H. Y., Olaoye, O., Rutter, V., Babar, Z-U-D. & The C. P. A. COVID-19 Action Team, 21 Oct 2020, In: Journal of Pharmaceutical Policy and Practice. 13, 1, 11 p., 72.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Needs Assessment 100%
  • Pharmacy 86%
  • Pandemics 79%
  • pharmacist 35%
  • Pharmacists 31%
  29 Citations (Scopus)

• Pharmaceutical Care of Patients with Cancer Treated on Non-Cancer Wards in the UK: A Mixed Methods Study

  Robertson, D. L. N. & Babar, Z. U. D., 1 May 2020, In: European Journal of Hospital Pharmacy. 27, 3, p. 143-150 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Pharmaceutical Services 100%
  • Pharmaceutical 58%
  • Pharmacy 53%
  • Pharmacists 52%
  • Neoplasms 25%
  1 Citation (Scopus)

• Pharmacists at the frontline beating the COVID-19 pandemic

  Bukhari, N., Rasheed, H., Nayyer, B. & Babar, Z., 20 Apr 2020, In: Journal of Pharmaceutical Policy and Practice. 13, 4 p., 8.

  Research output: Contribution to journal › Editorial › peer-review

  Open Access

  • pharmacist 100%
  • Pandemics 95%
  • Pharmacists 88%
  • Safety 76%
  • Pakistan 60%
  112 Citations (Scopus)

• Pharmacotherapeutic considerations for systemic rheumatic diseases amid the COVID-19 pandemic: more questions than answers

  Kow, C. S. & Hasan, S. S., 1 Nov 2020, In: Drugs and Therapy Perspectives. 36, 11, p. 518-522 5 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Coronavirus 100%
  • Rheumatic Diseases 84%
  • Pandemics 84%
  • Antirheumatic Agents 40%
  • Infections 16%
  2 Citations (Scopus)

• Pharmacotherapeutic considerations for the management of cardiovascular diseases among hospitalized COVID-19 patients

  Kow, C. S., Thiruchelvam, K. & Hasan, S. S., 1 Aug 2020, In: Expert Review of Cardiovascular Therapy. 18, 8, p. 475-485 11 p.

  Research output: Contribution to journal › Review article › peer-review

  • Cardiovascular Diseases 100%
  • Anticoagulants 42%
  • Antihypertensive Agents 42%
  • Comorbidity 36%
  • Hypokalemia 27%
  3 Citations (Scopus)

• Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety

  Akhtar, S., Benter, I. F., Danjuma, M. I., Doi, S. A. R., Hasan, S. S. & Habib, A. M., 13 Sep 2020, In: Journal of Drug Targeting. 28, 7-8, p. 683-699 17 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Receptor Blocking Agent 100%
  • Angiotensin II 78%
  • Safety 52%
  • Angiotensin Receptor Antagonists 52%
  • Angiotensin-Converting Enzyme Inhibitors 45%
  32 Citations (Scopus)

• Pharmacy, pharmaceuticals and public policy: Solving the puzzle

  Nagaria, R. A., Hasan, S. S. & Babar, Z. U. D., 1 Jun 2020, In: Research in Social and Administrative Pharmacy. 16, 6, p. 840-843 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Drug and Narcotic Control 100%
  • Public Policy 96%
  • Pharmacy 87%
  • Pharmaceutical 63%
  • Pharmacists 57%
  4 Citations (Scopus)

• Pharmacy Practice and Policy Research in Pakistan: A Review of Literature Between 2014 and 2019

  Malik, I., Atif, M., Scahill, S. L. & Babar, Z., 16 Jun 2020, Global Pharmaceutical Policy. Babar, Z-U-D. (ed.). 1st ed. Springer Singapore, p. 139-175 37 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

  • Pharmacy practices 100%
  • Pakistan 83%
  • research policy 75%
  • Pharmacy 74%
  • Pharmacovigilance 32%
  14 Citations (Scopus)

• Pharmacy Practice Research Methods

  Babar, Z. (ed.), 22 Apr 2020, 2nd ed. Springer Singapore. 265 p.

  Research output: Book/Report › Book › peer-review

  • Pharmacy Research 100%
  • Pharmacy 19%
  • Qualitative Research 11%
  • Health Services Research 11%
  • Quality Improvement 9%
  5 Citations (Scopus)

• Pharmacy Services beyond the Basics: A Qualitative Study to Explore Perspectives of Pharmacists towards Basic and Enhanced Pharmacy Services in Pakistan

  Atif, M., Razzaq, W., Mushtaq, I., Malik, I., Razzaq, M., Scahill, S. & Babar, Z-U-D., 1 Apr 2020, In: International Journal of Environmental Research and Public Health. 17, 7, 15 p., 2379.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Pharmaceutical Services 100%
  • Pakistan 90%
  • pharmacist 89%
  • Medicine 79%
  • Pharmacists 78%
  25 Citations (Scopus)

• PNS145 Access to Medicines in the United Kingdom: A Review of HTA Decisions for New Medicines

  Abbas, N., Hasan, S. S. & Babar, Z. U. D., 11 Dec 2020, In: Value in Health. 23, S2, p. S665 1 p., PNS145.

  Research output: Contribution to journal › Meeting Abstract › peer-review

  • Biomedical Technology Assessment 100%
  • technology assessment 93%
  • National Institutes of Health (U.S.) 81%
  • medicine 56%
  • Northern Ireland 52%

• Preventive measures and management of COVID‑19 in pregnancy

  Omer, S., Ali, S. & Babar, Z-U-D., 1 Jun 2020, In: Drugs and Therapy Perspectives. 36, 6, p. 246-249 4 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Coronavirus 100%
  • Severe Acute Respiratory Syndrome 68%
  • Pregnancy 48%
  • Global Health 25%
  • Italy 25%
  23 Citations (Scopus)

• Role of flame-retardants as EDCs in metabolic disorders

  Hussain, T., Yousaf, A., Ghori, M. U., Khan, I. U., Chohan, T. A., Rizvi, S. & Shahzad, Y., 5 Aug 2020, Endocrine Disrupting Chemicals-induced Metabolic Disorders and Treatment Strategies. Akash, M. S. H., Rehman, K. & Hashmi, M. Z. (eds.). 1st ed. Springer Nature Switzerland AG, p. 221-238 18 p. (Emerging Contaminants and Associated Treatment Technologies).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

  Open Access

  File

  • metabolic diseases 100%
  • flame retardants 97%
  • adverse effects 27%
  • biological hazards 24%
  • reproductive toxicology 21%

• Smoking Cessation Amid the Coronavirus 2019 Pandemic: Making Every Contact Count

  Shahzad Hasan, S., Kow, C. S. & Ahmadi, K., 21 Oct 2020, In: Chronic Obstructive Pulmonary Diseases. 7, 4, p. 300-302 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  1 Citation (Scopus)

• Strategies to improve insulin prescribing in UK hospitals: results from a national survey

  Bain, A., Hasan, S. S., Kavanagh, S. & Babar, Z-U-D., 17 Apr 2020, In: International Journal of Pharmacy Practice. 28, S1, p. 44-45 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

  • Insulin Derivative 100%
  • Insulin 66%
  • chronic illness 55%
  • pharmacist 46%
  • electronics 29%

• Strategies to reduce insulin prescribing errors in UK hospitals: results from a national survey

  Bain, A., Hasan, S. S., Kavanagh, S. & Babar, Z-U-D., 1 Jul 2020, In: Diabetic Medicine. 37, 7, p. 1176-1184 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Insulin 100%
  • Electronic Prescribing 37%
  • Pharmacists 36%
  • National Health Programs 25%
  • Self Administration 14%
  8 Citations (Scopus)

• Systematic Reviews and Meta-Analysis in Pharmacy Practice

  Hasan, S. S., Kairuz, T., Thiruchelvam, K. & Babar, Z., 22 Apr 2020, Pharmacy Practice Research Methods. Babar, Z-U-D. (ed.). 2nd ed. Springer Singapore, p. 237-250 14 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

  • Pharmacy 100%
  • Meta-Analysis 73%
  • Systematic Reviews 73%
  • Pharmacists 24%
  • Delivery of Health Care 15%
  2 Citations (Scopus)

• The community pharmacy practice change towards patient-centered care in Saudi Arabia: a qualitative perspective

  Kamran Rasheed, M., Alqasoumi, A., Hasan, S. S. & Babar, Z-U-D., 1 Dec 2020, In: Journal of Pharmaceutical Policy and Practice. 13, 1, 9 p., 59.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  33 Citations (Scopus)

• The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis

  Rong, X., Yin, J., Duan, S., Sun, Q. & Babar, Z., 29 Apr 2020, In: BMC Public Health. 20, 1, 10 p., 588.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Medicine costs 100%
  • Interrupted Time Series Analysis 75%
  • time series analysis 68%
  • pricing 54%
  • China 44%
  9 Citations (Scopus)

• The Fourth Industrial Revolution: Will it change pharmacy practice?

  Baines, D., Nørgaard, L. S., Babar, Z-U-D. & Rossing, C., 1 Sep 2020, In: Research in Social and Administrative Pharmacy. 16, 9, p. 1279-1281 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Robotics 100%
  • Pharmaceutical Industry 85%
  • Biotechnology 85%
  • Pharmacy 82%
  • Energy Storage 69%
  32 Citations (Scopus)

• The Future of Pharmacy Practice Research

  Babar, Z. & Birna Almarsdóttir, A., 22 Apr 2020, Pharmacy Practice Research Methods. Babar, Z-U-D. (ed.). 2nd ed. Springer Singapore, p. 251-265 15 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

  • Pharmacy Research 100%
  • Pharmacy 39%
  • Pharmaceutical Technology 30%
  • Cultural Diversity 28%
  • Consumer Behavior 27%
  3 Citations (Scopus)

• The Need for an Evidence-Based Encyclopaedia in Health Services Research in Pharmacy

  Babar, Z-U-D., 8 Apr 2020, In: International Journal of Environmental Research and Public Health. 17, 7, 4 p., 2549.

  Research output: Contribution to journal › Editorial › peer-review

  Open Access

  • encyclopedia 100%
  • Encyclopedias 85%
  • health services 80%
  • Health Services Research 75%
  • Pharmacy 66%
  4 Citations (Scopus)

• The optimal time to the resumption of biologics after COVID-19

  Kow, C. S. & Hasan, S. S., 1 Dec 2020, In: JAAD International. 1, 2, p. 189 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access
  1 Citation (Scopus)

• The Potential Benefit of Telmisartan to Protect Overweight Patients with COPD from the Acquisition of COVID-19

  Kow, C. S. & Hasan, S. S., 1 Nov 2020, In: Obesity. 28, 11, p. 2035 1 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

  • Telmisartan 100%
  • Chronic Obstructive Pulmonary Disease 62%
  • Severe Acute Respiratory Syndrome 45%
  • Coronavirus 44%
  • Enzymes 38%
  2 Citations (Scopus)

• The Use of Pharmacological Preventive Therapy for Migraine With Weight Gain Potential Amid Coronavirus Disease 2019 Pandemic

  Kow, C. S. & Hasan, S. S., 1 Oct 2020, In: Headache. 60, 9, p. 2085-2086 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Together we unite: the role of the Commonwealth in achieving universal health coverage through pharmaceutical care amidst the COVID-19 pandemic

  Chan, A. H. Y., Rutter, V., Ashiru-Oredope, D., Tuck, C. & Babar, Z., 13 May 2020, In: Journal of Pharmaceutical Policy and Practice. 13, 1, 7 p., 13.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Universal Health Insurance 100%
  • health coverage 97%
  • Pharmaceutical Services 92%
  • Pandemics 78%
  • pharmaceutical 68%
  18 Citations (Scopus)

• Translation, cultural adaptation and psychometric validation of the SF-6D measure of health-related quality of life for use in Arabic-Speaking countries

  Dawoud, D., El-Dahiyat, F., Abojedi, A., Dawoud, N., Soliman, A., Hussein, M., Mohamed, O., Hasan, S. S., Babar, Z-U-D. & Kharroubi, S., 1 Dec 2020, In: Research in Social and Administrative Pharmacy. 16, 12, p. 1754-1759 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Psychometrics 100%
  • Quality of Life 68%
  • Weight 56%
  • Health 52%
  • Weights and Measures 51%
  5 Citations (Scopus)

• Treatment outcomes of extrapulmonary tuberculosis in Bahawalpur, Pakistan: a record review

  Atif, M., Fatima, R., Ahmad, N. & Babar, Z-U-D., 24 Jul 2020, In: Journal of Pharmaceutical Policy and Practice. 13, 1, 7 p., 35.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Pakistan 100%
  • contagious disease 86%
  • Tuberculosis 72%
  • Lost to Follow-Up 19%
  • Medical records 17%
  10 Citations (Scopus)

• Understanding the factors influencing healthcare providers’ burnout during the outbreak of COVID-19 in Jordanian hospitals

  Algunmeeyn, A., El-Dahiyat, F., Mitib Altakhineh, M., Azab, M. & Babar, Z-U-D., 22 Sep 2020, In: Journal of Pharmaceutical Policy and Practice. 13, 1, 8 p., 53.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Healthcare Providers 100%
  • Psychological Burnout 98%
  • burnout 85%
  • Disease Outbreaks 74%
  • Health Personnel 73%
  68 Citations (Scopus)

• Use and validation of a survey tool to measure the perceived effectiveness of insulin‐prescribing safety interventions in UK hospitals

  Bain, A., Hasan, S. S., Kavanagh, S. & Babar, Z. . ., 1 Dec 2020, In: Diabetic Medicine. 37, 12, p. 2027-2034 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Insulin 100%
  • Safety 85%
  • Electronic Prescribing 24%
  • Hospital Medicine 21%
  • Self Administration 19%
  2 Citations (Scopus)